3 Results for "

ITD1

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "ITD1" in MCE Product Catalog:

6
6 Cited Publications
Cat. No.: HY-12704
CAS No.: 1099644-42-4
Purity:  99.41%
Target:  

TGF-β Receptor

Research Areas:  

Cardiovascular Disease

ITD-1 is the first selective TGFβ receptor inhibitor with an IC50 of 460 nM.
loading...
    loading...
Cat. No.: HY-137063
CAS No.: 1409968-46-2
Research Areas:  

Cardiovascular Disease

(+)-ITD-1 is an inhibitor for TGF-β, that inhibits the TGF-β2 with an IC50 of 0.46 μM. (+)-ITD-1 promotes the degradation of TGF-b type II receptor (TGFBR2) and the differentiation of cardiomyocyte, and inhibits the mesoderm formation in the early differentiation stage of mouse embryonic stem cells (mESCs) [1].
loading...
    loading...
Cat. No.: HY-170576
Target:  

FLT3 STAT Apoptosis

Research Areas:  

Cancer

FLT3-IN-28 (Compound 12y) is an orally active FLT3 inhibitor with antitumor activity. FLT3-IN-28 selectively inhibits cancer cells harboring the FLT3 internal tandem duplication (ITD) mutation, with IC50 values of 85, 290, 130, 65, and 220 nM for BaF3-FLT3-ITD, BaF3-TEL-VEGFR2, MV4-11, MOLM-13, and MOLM-14 cell lines respectively (MV4-11 and MOLM-13/14 are acute myeloid leukemia (AML) cell lines carrying the FLT3-ITD mutation). Additionally, FLT3-IN-28 can downregulate the phosphorylation levels of FLT3 and STAT5 in MOLM-13 cells and induce cell cycle arrest and Apoptosis. FLT3-IN-28 has an oral bioavailability of 19.2% in SD rats and can prolong survival in a dose-dependent manner in NSG mice xenografted with MOLM-13 cells. FLT3-IN-28 holds promise for research in cancer fields related to FLT3-ITD .
loading...
    loading...